Abstract:Ischemic heart disease, which is one of the top killers worldwide, encompasses a series of heart problems stemming from a compromised coronary blood supply to the myocardium. The severity of the disease ranges from an unstable manifestation of ischemic symptoms, such as unstable angina, to myocardial death, that is, the immediate life-threatening condition of myocardial infarction. Even though patients may survive myocardial infarction, the resulting ischemia-reperfusion injury triggers a cascade of inflammatory reactions and oxidative stress that poses a significant threat to myocardial function following successful revascularization. Moreover, despite evidence suggesting the presence of cardiac stem cells, the fact that cardiomyocytes are terminally differentiated and cannot significantly regenerate after injury accounts for the subsequent progression to ischemic cardiomyopathy and ischemic heart failure, despite the current advancements in cardiac medicine. In the last two decades, researchers have realized the possibility of utilizing stem cell plasticity for therapeutic purposes. Indeed, stem cells of different origin, such as bone-marrow- and adipose-derived mesenchymal stem cells, circulation-derived progenitor cells, and induced pluripotent stem cells, have all been shown to play therapeutic roles in ischemic heart disease. In addition, the discovery of stem-cell-associated paracrine effects has triggered intense investigations into the actions of exosomes. Notwithstanding the seemingly promising outcomes from both experimental and clinical studies regarding the therapeutic use of stem cells against ischemic heart disease, positive results from fraud or false data interpretation need to be taken into consideration. The current review is aimed at overviewing the therapeutic application of stem cells in different categories of ischemic heart disease, including relevant experimental and clinical outcomes, as well as the proposed mechanisms underpinning such observations.

Regenerative Therapy for Cardiomyopathies

The Challenges Of Stem Cell Therapy In Myocardial Infarction And Heart Failure And The Potential Strategies To Improve The Outcomes

Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications.

Concise Review: Optimized Strategies for Stem Cell-based Therapy in Myocardial Repair: Clinical Translatability and Potential Limitation.

Current Optimized Strategies for Stem Cell-Derived Extracellular Vesicle/exosomes in Cardiac Repair.

Stem cell and exosome therapies for regenerating damaged myocardium in heart failure

Cell Therapy and 3D Regenerative Tissue to Remodel Heart Failure

Stem Cell Therapy For Ischemic Heart Diseases

Mini Review: Recent Advances in the Cell-Based Therapies for Cardiac Regeneration.

The Origin, Progress, and Application of Cell‐based Cardiac Regeneration Therapy

Stem cell therapy for cardiac regeneration: past, present, and future

The Recent Advances in Cell Delivery Approaches, Biochemical and Engineering Procedures of Cell Therapy Applied to Coronary Heart Disease

Current situation and future of stem cells in cardiovascular medicine

Heart Regeneration with Embryonic Cardiac Progenitor Cells and Cardiac Tissue Engineering.

Cardiac Progenitor/stem Cells on Myocardial Infarction or Ischemic Heart Disease: What We Have Known from Current Research

Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation

Stem Cell Therapy against Ischemic Heart Disease

Cardiac Cell Therapy for Heart Repair: Should the Cells Be Left Out?

Potential Mechanisms Underlying Therapeutic Benefits of Stem Cell for Heart Failure

Biomaterials‐based Cell Therapy for Myocardial Tissue Regeneration

Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells